Why the study?
Lean diabetic patients with HFpEF suffer from adverse outcomes, but suitable animal models are urgently needed for mechanistic study and therapeutic innovations.
Seipin knockout mice provide a novel animal model for lean diabetic HFpEF, revealing titin phosphorylation and neutrophil extracellular traps as potential therapeutic targets.
The lean diabetic patients with heart failure with preserved ejection fraction (HFpEF) in Asia suffer from adverse clinical outcomes and poor life quality. The suitable animal models are urgently needed for mechanistic study and therapeutic innovations. Our study reports that lipodystrophic mice with seipin depletion are lean, diabetic, and recapitulate major manifestations of clinical HFpEF, thereby clarifying that lean diabetes per se may produce HFpEF characteristics. We further demonstrate that increased cardiac titin phosphorylation and reactive interstitial fibrosis associated with neutrophil extracellular traps lead to left ventricular stiffness and suggest that both pathways may be potential therapeutic targets in Asian HFpEF patients.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: